CVS Health is reportedly closing down a number of its pharmacies installed in Target stores in the United States. The pharmacies are expected to be removed from the discount department store chain’s locations in early 2024.
As per CNN Business, the spokesperson of CVS Health confirmed the closure of its drug stores on Thursday, Jan. 11. It was said that the decision to stop its operations inside the Target outlets comes as retail pharmacy companies in the U.S. are faced with growing difficulties with their workforce, prescriptions business, and other aspects.
Schedule of the Pharmacy Shut Downs
The American retail pharmacy brand said it will close its stores in Target locations from next month until April this year. The company also said this is part of its strategy to spread out its stores and pharmacies even more. This information was shared with CNN through an email from CVS Pharmacy’s spokesperson, Amy Thibault.
The closing of the pharmacies is “based on our evaluation of changes in population, consumer buying patterns and future health needs to ensure we have the right pharmacy format in the right locations for patients,” the spokeswoman said.
Select Locations are Affected
Forbes reported that only select locations of Target stores are losing their CVS Health outlets this year. Then again, the company did not mention specific locations for the shutdown. The company is currently operating around 9,000 stores across the country.
“The pharmacy closures will begin in February and be completed by the end of April and impacted employees will be offered comparable roles within the company,” CVS Health said in a statement. “The closures are part of our plan to realign our national retail footprint and reduce store and pharmacy density and are based on our evaluation of changes in population, consumer buying patterns and future health needs to ensure we have the right pharmacy format in the right locations for patients.”
Photo by: Marques Thomas/Unsplash


Tesla's Terafab: AI Chip Factory Eyes Taiwan's Semiconductor Talent
ASML Raises 2026 Revenue Outlook as AI Chip Demand Surges
Apple Wins ITC Ruling, Keeping Blood-Oxygen Feature on Apple Watch
Samsung Races to Deliver Next-Gen HBM4E Memory Samples to Nvidia
Anthropic Nears $800 Billion Valuation as Investor Confidence Surges
OpenAI's $20 Billion Cerebras Deal Signals Massive AI Infrastructure Push
Sam Altman Moves to Dismiss Punitive Damages in Sister's Sexual Abuse Lawsuit
Federal Judge Dismisses DOJ Lawsuit Attempting to Block Hawaii's Climate Case Against Oil Giants
Goldman Sachs FICC Revenue Falls 10% Amid Iran War Market Volatility
Japan to Subsidize Sony's Image Sensor Plant in Kumamoto with $380 Million
Iran War Drives Asia's Plastic Crisis — and a Green Packaging Boom
DEEPX Partners with Hyundai to Power Next-Gen AI Robots Ahead of IPO
Greg Abel Sells Berkshire Hathaway Stocks Managed by Former Investment Manager Todd Combs
AEVEX Raises $320 Million in IPO Amid Surging Defense Sector Demand
Uber Bets Big on Autonomous Vehicles with $10 Billion Commitment
CATL Stock Hits Record High After Q1 2025 Earnings Surge
Elliott Investment Takes ~3% Stake in Daikin, Pushes for Buybacks and Strategic Overhaul 



